Cationic antimicrobial peptides do not change recombination frequency in Escherichia coli
Author(s) -
Alexandro Rodríguez-Rojas,
Javier Moreno,
A. James Mason,
Jens Rolff
Publication year - 2018
Publication title -
biology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.596
H-Index - 110
eISSN - 1744-957X
pISSN - 1744-9561
DOI - 10.1098/rsbl.2018.0006
Subject(s) - biology , antimicrobial peptides , escherichia coli , antimicrobial , innate immune system , antibiotic resistance , recombination , microbiology and biotechnology , antibiotics , multicellular organism , effector , dna , mutation , immune system , genetics , gene
Cationic antimicrobial peptides are ubiquitous immune effectors of multicellular organisms. We previously reported, that in contrast to most of the classic antibiotics, cationic antimicrobial peptides (AMPs) do not increase mutation rates inE. coli . Here, we provide new evidence showing that AMPs do not stimulate or enhance bacterial DNA recombination in the surviving fractions. Recombination accelerates evolution of antibiotic resistance. Our findings have implications for our understanding of host–microbe interactions, the evolution of innate immune defences, and shed new light on the dynamic of antimicrobial-resistance evolution.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom